Taking into consideration previous studies that have investigated the landscape of germline LGRs in breast and ovarian cancer, we conclude that our cohort contains a similar proportion of BRCA1/2 LGRs as was previously reported [8, 23, 26, 27]. This evidence concerns the gene BRCA1 and ovarian carcinoma.